Archive - June 2018
FDA Approves Olumiant (baricitinib) 2 mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis
Risks Of Antibiotics: Patients’ Perceptions Influence Doctors’ Prescriptions, Study Finds
Vaping A Gateway To Cigarettes For Youth, Experts Say, Want Flavors Banned
